CD52 expression in mantle cell lymphoma.

Journal Article

Mantle cell lymphoma is one of the most difficult to treat of all the non-Hodgkin's lymphomas. CAMPATH-1H, a humanized monoclonal antibody against the CD52 antigen, has been used with some success in other lymphoproliferative diseases, especially chronic lymphocytic leukemia. This report demonstrates that tumor samples from patients with mantle cell lymphoma express the CD52 antigen and suggests that CAMPATH-1H should be studied in patients with mantle cell lymphoma.

Full Text

Duke Authors

Cited Authors

  • Bass, AJ; Gong, J; Nelson, R; Rizzieri, DA

Published Date

  • February 2002

Published In

Volume / Issue

  • 43 / 2

Start / End Page

  • 339 - 342

PubMed ID

  • 11999566

Pubmed Central ID

  • 11999566

International Standard Serial Number (ISSN)

  • 1042-8194

Digital Object Identifier (DOI)

  • 10.1080/10428190290006125

Language

  • eng

Conference Location

  • United States